Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years
February 2, 2018Medical Communications, Sales and Marketing Allergan, Avycaz, FDA, pharma, pneumonia
Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the …
Incidence of strokes in younger people rising
February 1, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, stroke
On the day that a new campaign for greater awareness of stroke symptoms has been released, new figures show that …
Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe
February 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life
Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …
NICE approves Perjeta for routine use on NHS
February 1, 2018Sales and Marketing Perjeta, Roche, biotech, drugs, pharma, pharmaceutical
NICE has given the nod to Roche’s Perjeta for routine first-line use, alongside Herceptin and chemotherapy, in patients with HER2-positive …
FDA halts Bellicum trial over brain disease in participants, shares crash 48%
February 1, 2018Research and Development Bellicum Pharmaceuticals, FDA, encephalopathy, pharma, trial failure
Texas-based clinical-stage company Bellicum Pharmaceuticals has taken a massive stock hit after the FDA put a hold on its trials …
New blood test for Alzheimer’s offers hope
February 1, 2018Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical
To say January was a bleak month for Alzheimer’s research would be something of an understatement: Pfizer ducked out of …
Seattle in $614m move for Cascadian Therapeutics
January 31, 2018Sales and Marketing Cascadian Theapeutics, HER2, Seattle Genetics, biotech, drugs, pharma, pharmaceutical
Things don’t always go quite according to plan in the biotech world – something both Seattle Genetics and Cascadian Therapeutics …
CDC Director resigns over tobacco stock scandal
January 31, 2018Medical Communications Brenda Fitzgerald, CDC, US, pharma
Dr Brenda Fitzgerald, the Director of the Centers for Disease Control and Prevention, the United States’ leading national public health …
Ipsen promotes new CMO from within
January 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …
UK charity Breast Cancer Care receives £655,000 cash injection to expand end-of-treatment app
January 31, 2018Research and Development Breast Cancer Care, National lottery, UK, breast cancer, charity, pharma
UK charity Breast Cancer Care (BCC) is set to expand the development of its end-of-treatment support app after receiving a …
NHS Digital lambasted for collusion with Home Office to deport migrants
January 31, 2018Medical Communications, Research and Development NHS Digital, biotech, drugs, immigration, pharma, pharmaceutical
NHS Digital, the Department of Health and the Home Office have been strongly criticised for entering a memorandum of understanding …
Pfizer teams up with Indian Government to battle antimicrobial resistance
January 31, 2018Medical Communications, Research and Development India, Pfizer, antimicrobial resistance, pharma
Pfizer has entered into a partnership with the Indian Council of Medical Research (ICMR) in an effort to fight antimicrobial …
Amazon makes first steps into healthcare, alongside big partners
January 31, 2018Medical Communications, Research and Development Berkshire Hathaway, JPMorgan, amazon, biotech, drugs, pharma, pharmaceutical
Amazon’s move into the healthcare sector has been widely mooted over the last 12 months and it officially announced that …
Italy refuses to give up hope on EMA HQ
January 30, 2018Medical Communications, Research and Development EMA, amsterdam, biotech, drugs, pharma, pharmaceutical
It is no secret that Milan was not best pleased that it was pipped to the post to host the …
Read Pharmafocus January/February 2018 edition online now!
January 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Ablynx, Alex Azr, Celgene, Pharmafocus, Sanofi, UK, artificial intelligence, bioverativ, brexit, juno therapeutics, multiple myeloma, serialisation
With the holiday period a distant memory by now, Pharmafocus is back with its January/febraury edition. It’s hard to imagine …
Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi
January 30, 2018Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …
Apotex President resigns amidst Founder’s murder and allegations of accepting Teva secrets
January 30, 2018Manufacturing and Production, Medical Communications Apotex, Jeremy Desai, Teva, pharma
Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …
Celgene Executive Chairman Bob Hugin to retire
January 30, 2018Manufacturing and Production, Medical Communications Bob Hugin, Celgene, pharma
Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective …
FDA revises methods, after public outrage at testing of monkeys
January 29, 2018Manufacturing and Production, Medical Communications FDA, biotech, drugs, pharma, pharmaceutical
The story broke in September of last year that the FDA was testing nicotine addiction in squirrel monkeys and that …
Santhera’s Raxone rejected in Europe for Duchenne muscular dystrophy
January 29, 2018Sales and Marketing Duchenne Muscular Dystrophy, EMA, Europe Santhera, pharma
While the EMA’s Committee for Medicinal products for Human Use (CHMP) recommended a spree of treatments over the past week, …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
